Patents-Review.com
🔗 Permalink
Assignee profile:

Applied Molecular Evolution, Inc.

City:

San Diego, California

Country:

United States

Published Applications:

17

Last publication date:

2022-02-17

Patent Grants:

16

Last grant date:

2024-08-20

Top Inventors for applications by Applied Molecular Evolution, Inc.

These are the the leading inventors for applications assigned to Applied Molecular Evolution, Inc.:

Recent patent applications by Applied Molecular Evolution, Inc.

Applied Molecular Evolution, Inc. based in San Diego, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2022-02-17 ✅ Patent 12,065,488 granted on 2024-08-20
US20220048985A1
Chemistry; metallurgy

Anti-IL-6 antibody

 #2 | 2020-04-16 ✅ Patent 11,180,549 granted on 2021-11-23
US20200115445A1
Chemistry; metallurgy

Methods of suppressing rheumatoid arthritis using an anti-IL-6 antibody

 #3 | 2014-04-10 ✅ Patent 9,340,613 granted on 2016-05-17
US20140099311A1
Chemistry; metallurgy

Anti-IL-6 antibodies, compositions, methods and uses

 #4 | 2011-04-07 ✅ Patent 8,067,003 granted on 2011-11-29
US20110081355A1
Chemistry; metallurgy

Methods of treating conditions using anti-IL-6 antibodies

 #5 | 2010-09-23 ✅ Patent 8,153,133 granted on 2012-04-10
US20100239574A1
Chemistry; metallurgy

High potency recombinant antibodies and method for producing them

 #6 | 2009-12-03 ✅ Patent 8,105,597 granted on 2012-01-31
US20090297505A1
Chemistry; metallurgy

Aβ binding molecules

 #7 | 2009-01-22 ✅ Patent 7,667,007 granted on 2010-02-23
US20090023900A1
Chemistry; metallurgy

αvβ3-specific antibodies

 #8 | 2008-11-06 ✅ Patent 7,723,484 granted on 2010-05-25
US20080274114A1
Chemistry; metallurgy

Anti-EGFR antibodies

 #9 | 2008-09-09 ✅ Patent 7,422,745 granted on 2008-09-09
US10463847
-

Methods of treating cancer with αβ-specific antibodies

 #10 | 2008-09-09 ✅ Patent 7,422,744 granted on 2008-09-09
US10452440
-

Methods of treating cancer with alphavbeta3-specific antibodies

 #11 | 2008-05-13 ✅ Patent 7,371,382 granted on 2008-05-13
US10305231
-

Methods of inhibiting αβ-mediated binding with αβ-specific antibodies

 #12 | 2007-09-27 ✅ Patent 7,740,847 granted on 2010-06-22
US20070224188A1
Chemistry; metallurgy

Variant Fc regions

 #13 | 2006-11-16 ✅ Patent 7,560,112 granted on 2009-07-14
US20060257407A1
Chemistry; metallurgy

Anti-il-6 antibodies, compositions, methods and uses

 #14 | 2006-11-09 ✅ Patent 8,153,125 granted on 2012-04-10
US20060251652A1
Chemistry; metallurgy

CD20 binding molecules

 #15 | 2006-06-29 ✅ Patent 7,541,033 granted on 2009-06-02
US20060140932A1
Chemistry; metallurgy

Humanized anti-IL-1β antibodies

 #16 | 2005-05-17 ✅ Patent 6,893,845 granted on 2005-05-17
US8471622
-

Surface expression libraries of heteromeric receptors

 #17 | 2005-01-06
US20050003469A1
Chemistry; metallurgy

Tumor specific human monoclonal antibodies and methods of use

Also check out Applied Molecular Evolution, Inc.'s (San Diego, United States) applicant profile with 3 patent applications submitted.

AssigneeID:

60939 ⎘